Characterizing dedifferentiation of thyroid cancer by integrated analysisHan Luo, Heng Xu, Xuyang Xia et al.|Science Advances|2021Cited by 177
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid CancerQing Hao, Binwu Ying, Ruicen Li et al.|Advanced Science|2024Cited by 7
Protocolisation, utilisation et développement des médicaments anticancéreux dans le cadre de la mise en place de la T2AA. Mathieu-Boué, Patrice Viens, Robert Benamouzig et al.|Therapies|2006Cited by 1